A cost-effectiveness analysis of the IBD-BOOST randomized controlled trial found that a facilitator-supported digital self-management program is highly likely to be a cost-effective addition to standard care for people with inflammatory bowel disease (IBD) experiencing persistent pain, fatigue, and fecal incontinence. Although the original trial…
Atlanta Gastroenterology Associates has agreed to pay $4.75 million to settle allegations that it violated the False Claims Act by…
The U.S. healthcare system is approaching a tipping point, driven by three converging threats: rising care costs, a growing chronic…
In a bid to close persistent colorectal cancer (CRC) screening gaps, Guardant Health has launched a community grant program offering…
The 2025 Identity Theft Resource Center report confirms what many physician-owners are feeling: cyberattacks are no longer random — they’re…
DDW 2026
Several studies presented at DDW 2026 highlighted emerging approaches that could reshape…
A structured triage system for interventional GI referrals changed the originally requested…
Headlines in GI
Two gastroenterology organizations have disclosed phishing-related data breaches that exposed sensitive patient…
In this perspective, Dr. Aasma Shaukat contends that the American Cancer Society’s…
Thought Leadership
This GI & Hepatology News Perspectives article provides practical guidance from experienced endoscopists on two key endoscopic topics: the management of Barrett’s esophagus and…
In the latest edition of The Scope Forward Show, I’m joined by Matt…
How GI Becomes the Coordinator of Digestive Health By Dr. Charles Accurso…
Roughly half of patients with an abnormal stool-based colorectal cancer screening result…
ARTIFICIAL INTELLIGENCE (AI)
Tech & Innovation
Business
Physician practice consolidation continues to reshape the U.S. healthcare landscape, with Becker’s…